inTEST (NYSE:INTT) Price Target Lowered to $16.00 at Lake Street Capital

inTEST (NYSE:INTT) had its price target decreased by Lake Street Capital from $19.00 to $16.00 in a report released on Tuesday, Benzinga reports. Lake Street Capital currently has a buy rating on the stock.

Separately, StockNews.com lowered inTEST from a buy rating to a hold rating in a research note on Saturday, April 6th.

inTEST Stock Down 7.9 %

INTT opened at $10.77 on Tuesday. The business has a 50 day moving average price of $11.69 and a two-hundred day moving average price of $12.24. inTEST has a 52 week low of $9.71 and a 52 week high of $27.17. The company has a market cap of $134.52 million, a PE ratio of 12.67 and a beta of 2.01. The company has a quick ratio of 2.70, a current ratio of 3.53 and a debt-to-equity ratio of 0.09.

inTEST (NYSE:INTT) last announced its quarterly earnings data on Wednesday, March 27th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.04. inTEST had a net margin of 8.02% and a return on equity of 13.46%. The business had revenue of $27.88 million for the quarter, compared to the consensus estimate of $32.70 million. As a group, research analysts anticipate that inTEST will post 1.04 EPS for the current year.

Insider Buying and Selling

In other inTEST news, CEO Richard N. Jr. Grant sold 21,500 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The stock was sold at an average price of $12.03, for a total value of $258,645.00. Following the completion of the transaction, the chief executive officer now owns 171,717 shares in the company, valued at approximately $2,065,755.51. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO Richard N. Jr. Grant sold 20,000 shares of the stock in a transaction dated Tuesday, April 9th. The shares were sold at an average price of $12.80, for a total transaction of $256,000.00. Following the transaction, the chief executive officer now owns 215,217 shares of the company’s stock, valued at $2,754,777.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Richard N. Jr. Grant sold 21,500 shares of the business’s stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $12.03, for a total value of $258,645.00. Following the completion of the sale, the chief executive officer now directly owns 171,717 shares of the company’s stock, valued at $2,065,755.51. The disclosure for this sale can be found here. 5.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On inTEST

Institutional investors have recently made changes to their positions in the company. Stansberry Asset Management LLC boosted its holdings in inTEST by 145.8% in the third quarter. Stansberry Asset Management LLC now owns 113,911 shares of the company’s stock worth $1,728,000 after purchasing an additional 67,561 shares during the period. Great Valley Advisor Group Inc. bought a new stake in shares of inTEST during the 3rd quarter valued at about $167,000. First Eagle Investment Management LLC raised its stake in inTEST by 49.0% during the third quarter. First Eagle Investment Management LLC now owns 359,948 shares of the company’s stock worth $5,460,000 after acquiring an additional 118,449 shares during the period. WINTON GROUP Ltd bought a new position in shares of inTEST during the third quarter valued at approximately $309,000. Finally, Barclays PLC boosted its holdings in shares of inTEST by 161.9% during the third quarter. Barclays PLC now owns 7,521 shares of the company’s stock valued at $114,000 after acquiring an additional 4,649 shares during the period. 63.18% of the stock is currently owned by institutional investors.

inTEST Company Profile

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.